PharVision Advisers’s Ellington Residential Mortgage REIT EARN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,281
Closed -$66.9K 768
2025
Q3
$66.9K Sell
12,281
-5,410
-31% -$31.2K 0.04% 643
2025
Q2
$102K Buy
17,691
+528
+3% +$2.88K 0.15% 252
2025
Q1
$92.9K Buy
+17,163
New +$109K 0.13% 251

Other funds holding EARN

PharVision Advisers's EARN Position: Q4 2025 in Review

PharVision Advisers sold out of Ellington Residential Mortgage REIT (EARN) in Q4 2025, closing a stake of 12,281 shares — an estimated $66.9K sold.

PharVision Advisers first reported a position in EARN in Q1 2025 and held it in 3 quarters. The position peaked at $102K in Q2 2025. 45 funds tracked by Wall St. Rank hold EARN as of Q4 2025.

  • PharVision Advisers reported no remaining Ellington Residential Mortgage REIT position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 12,281 Ellington Residential Mortgage REIT shares in Q4 2025, an estimated $66.9K.
  • PharVision Advisers first reported a position in Ellington Residential Mortgage REIT in Q1 2025 and held it in 3 quarters.
  • PharVision Advisers's Ellington Residential Mortgage REIT position peaked at $102K in Q2 2025.
  • 45 funds tracked by Wall St. Rank held Ellington Residential Mortgage REIT as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.